IL264294B - Treatment and prevention of sleep disorders - Google Patents
Treatment and prevention of sleep disordersInfo
- Publication number
- IL264294B IL264294B IL264294A IL26429419A IL264294B IL 264294 B IL264294 B IL 264294B IL 264294 A IL264294 A IL 264294A IL 26429419 A IL26429419 A IL 26429419A IL 264294 B IL264294 B IL 264294B
- Authority
- IL
- Israel
- Prior art keywords
- prevention
- treatment
- sleep disorders
- sleep
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Acoustics & Sound (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662366960P | 2016-07-26 | 2016-07-26 | |
| US201762536097P | 2017-07-24 | 2017-07-24 | |
| PCT/IB2017/054506 WO2018020418A1 (en) | 2016-07-26 | 2017-07-25 | Treatment and prevention of sleep disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL264294A IL264294A (en) | 2019-02-28 |
| IL264294B true IL264294B (en) | 2022-06-01 |
Family
ID=59714072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL264294A IL264294B (en) | 2016-07-26 | 2019-01-17 | Treatment and prevention of sleep disorders |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US10974081B2 (https=) |
| EP (1) | EP3490563A1 (https=) |
| JP (2) | JP7198197B2 (https=) |
| KR (2) | KR102210209B1 (https=) |
| CN (1) | CN109689058B (https=) |
| AU (2) | AU2017304898B2 (https=) |
| BR (1) | BR112019001457A2 (https=) |
| CA (1) | CA3031388C (https=) |
| CL (1) | CL2019000190A1 (https=) |
| EC (1) | ECSP19014247A (https=) |
| IL (1) | IL264294B (https=) |
| JO (1) | JOP20190008A1 (https=) |
| MX (1) | MX388469B (https=) |
| NZ (1) | NZ750817A (https=) |
| PH (1) | PH12019500177A1 (https=) |
| SG (1) | SG11201900486WA (https=) |
| TN (1) | TN2019000019A1 (https=) |
| TW (1) | TWI661827B (https=) |
| WO (1) | WO2018020418A1 (https=) |
| ZA (1) | ZA201901055B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190008A1 (ar) | 2016-07-26 | 2019-01-24 | Purdue Pharma Lp | علاج ومنع اضطرابات النوم |
| JP7108041B2 (ja) * | 2018-01-24 | 2022-07-27 | パーデュー、ファーマ、リミテッド、パートナーシップ | 睡眠障害の治療及び予防 |
| CA3097445A1 (en) * | 2018-04-16 | 2019-10-24 | Technologies Hop-Child, Inc. | Systems and methods for the determination of arousal states, calibrated communication signals and monitoring arousal states |
| KR102198846B1 (ko) * | 2018-06-29 | 2021-01-05 | 다인기술 주식회사 | 배뇨에 관한 설문을 수행하는 방법, 시스템 및 비일시성의 컴퓨터 판독 가능 기록 매체 |
| US11547350B2 (en) | 2018-12-26 | 2023-01-10 | Industrial Technology Research Institute | Personalized parameter learning method, sleep-aid device and non-transitory computer readable medium |
| CN111359074B (zh) * | 2018-12-26 | 2022-08-02 | 财团法人工业技术研究院 | 个人化参数学习方法、睡眠辅助装置及存储介质 |
| CN113301957A (zh) * | 2019-01-31 | 2021-08-24 | 普渡制药公司 | 取代的喹喔啉型桥接哌啶化合物的多晶型形式 |
| BR112022004576A2 (pt) * | 2019-09-13 | 2022-06-14 | Takeda Pharmaceuticals Co | Métodos para diminuir ou tratar sonolência excessiva, tratar narcolepsia tipo 2 ou hipersonia idiopática, tratar distúrbio de trabalho de turno, aumentar latência de sono em manutenção de teste de insônia, melhorar classificação de escaça de sonolência de karolinska, diminuir ou melhorar sonolência subjetiva, aumentar insônia ou diminuir sonolência excessiva, melhorar classificação de escala de sonolência epworth, tratar narcolepsia tipo 2, diminuir ou tratar sonolência diurna excessiva, e, composição farmacêutica |
| CN114159568B (zh) * | 2020-09-11 | 2025-08-01 | 北京原基华毅生物科技有限公司 | Sik抑制剂在制备用于预防和/或治疗睡眠障碍的药物中的应用 |
| MX2023013514A (es) | 2021-05-21 | 2024-04-02 | Purdue Pharma Lp | Metodos para tratar la cistitis intersticial/sindrome de dolor en la vejiga. |
| TWI804037B (zh) | 2021-11-02 | 2023-06-01 | 長庚醫療財團法人高雄長庚紀念醫院 | 生酮飲食之評估系統及其運作方法 |
| KR20250026332A (ko) * | 2022-06-24 | 2025-02-25 | 퍼듀 퍼머 엘피 | 과민성 방광 증후군의 치료 또는 예방 방법 |
| WO2025085818A1 (en) | 2023-10-19 | 2025-04-24 | Purdue Pharma L.P. | Sunobinop for use in method of treating alcohol use disorder |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| ES2247604T3 (es) | 1995-06-12 | 2006-03-01 | G.D. SEARLE & CO. | Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa. |
| US6572891B1 (en) | 1999-10-23 | 2003-06-03 | Alkaloid Ad | Sublingual oral dosage form |
| JP4056977B2 (ja) | 2002-03-29 | 2008-03-05 | 田辺三菱製薬株式会社 | 睡眠障害治療薬 |
| JP4739217B2 (ja) | 2003-05-07 | 2011-08-03 | サムヤン コーポレイション | 速く溶ける錠剤を製造するための高可塑性顆粒 |
| AR045939A1 (es) | 2003-09-25 | 2005-11-16 | Solvay Pharm Bv | Derivados de bencimidazolona y quinazolinona como agonistas de los receptores orl 1 humanos |
| US7355045B2 (en) | 2004-01-05 | 2008-04-08 | Applera Corporation | Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof |
| WO2006025267A1 (ja) * | 2004-08-31 | 2006-03-09 | Mitsubishi Pharma Corporation | Per2タンパク質レベルの低下を作用機序とする睡眠障害治療薬 |
| WO2008033024A2 (en) | 2006-09-15 | 2008-03-20 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| MY150602A (en) * | 2007-08-31 | 2014-01-30 | Purdue Pharma Lp | Subtituted-quinoxaline-type piperidine compounds and the uses thereof |
| TWI441658B (zh) | 2008-03-11 | 2014-06-21 | Takeda Pharmaceutical | 口腔崩解固體製劑 |
| KR101333660B1 (ko) * | 2008-07-21 | 2013-11-27 | 시오노기세이야쿠가부시키가이샤 | 치환-퀴녹살린-형 가교-피페리딘 화합물 및 그의 용도 |
| AU2012324015A1 (en) | 2011-12-01 | 2013-06-20 | Purdue Pharma L.P. | Azetidine-substituted quinoxaline-type piperidine compounds and uses thererof |
| WO2014102592A2 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Oxime/substituted quinoxaline-type piperidine compounds and uses thereof |
| US10118927B2 (en) * | 2012-12-27 | 2018-11-06 | Purdue Pharma L.P. | Substituted piperidin-4-amino-type compounds and uses thereof |
| JOP20190008A1 (ar) | 2016-07-26 | 2019-01-24 | Purdue Pharma Lp | علاج ومنع اضطرابات النوم |
-
2017
- 2017-06-16 JO JOP/2019/0008A patent/JOP20190008A1/ar unknown
- 2017-07-25 KR KR1020197004527A patent/KR102210209B1/ko active Active
- 2017-07-25 WO PCT/IB2017/054506 patent/WO2018020418A1/en not_active Ceased
- 2017-07-25 EP EP17758282.2A patent/EP3490563A1/en active Pending
- 2017-07-25 KR KR1020217002556A patent/KR102531366B1/ko active Active
- 2017-07-25 BR BR112019001457-8A patent/BR112019001457A2/pt not_active Application Discontinuation
- 2017-07-25 CA CA3031388A patent/CA3031388C/en active Active
- 2017-07-25 SG SG11201900486WA patent/SG11201900486WA/en unknown
- 2017-07-25 US US16/318,686 patent/US10974081B2/en active Active
- 2017-07-25 NZ NZ750817A patent/NZ750817A/en unknown
- 2017-07-25 JP JP2019503994A patent/JP7198197B2/ja active Active
- 2017-07-25 TW TW106124940A patent/TWI661827B/zh active
- 2017-07-25 AU AU2017304898A patent/AU2017304898B2/en active Active
- 2017-07-25 MX MX2019001036A patent/MX388469B/es unknown
- 2017-07-25 TN TNP/2019/000019A patent/TN2019000019A1/en unknown
- 2017-07-25 CN CN201780046414.XA patent/CN109689058B/zh active Active
-
2019
- 2019-01-17 IL IL264294A patent/IL264294B/en unknown
- 2019-01-25 CL CL2019000190A patent/CL2019000190A1/es unknown
- 2019-01-25 PH PH12019500177A patent/PH12019500177A1/en unknown
- 2019-02-19 ZA ZA2019/01055A patent/ZA201901055B/en unknown
- 2019-02-26 EC ECSENADI201914247A patent/ECSP19014247A/es unknown
-
2020
- 2020-11-19 AU AU2020273332A patent/AU2020273332B2/en active Active
-
2021
- 2021-03-08 US US17/195,434 patent/US11738023B2/en active Active
- 2021-04-21 JP JP2021072166A patent/JP7291172B2/ja active Active
-
2023
- 2023-06-28 US US18/343,182 patent/US12370191B2/en active Active
-
2025
- 2025-06-16 US US19/239,541 patent/US20260007660A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201901055B (en) | Treatment and prevention of sleep disorders | |
| IL277648A (en) | Medical microbiota for the treatment and/or prevention of food allergy | |
| IL269302A (en) | Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders | |
| GB201501983D0 (en) | Treatment of snoring and sleep apnoea | |
| EP3104776A4 (en) | Diagnosis and treatment of respiratory disorders | |
| IL264451B1 (en) | A combination of abt-199 and achmetalstat for the treatment of aml | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| IL263477A (en) | Compositions and methods for the treatment or prevention of oxalate-related disorders | |
| ZA201902091B (en) | Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders | |
| IL265693A (en) | Prevention and treatment of diabetic kidney disease | |
| IL314274A (en) | Treatment of skin disorders | |
| GB201413530D0 (en) | Treatment and prevention of malaria | |
| IL260987A (en) | Treatment and diagnosis of inflammatory disorders | |
| IL275875A (en) | Treatment and prevention of sleep disorders | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| PT3197556T (pt) | Composição para a prevenção e/ou tratamento de sintomas de alergia | |
| ZA202002910B (en) | Treatment of skin disorders | |
| GB201615298D0 (en) | Treatment and prevention of Malaria | |
| IL258316A (en) | A combination of trazodone and gabapentin for the treatment of pain | |
| IL248381A0 (en) | A combination of brexpiprazole and nalemapine and its use in the treatment of drug-related disorders | |
| LT3137093T (lt) | Alzheimerio ligos (ad) gydymas ir prevencija | |
| GB201604359D0 (en) | Treatment of tissue disorders | |
| HUE053774T2 (hu) | Gyógynövények kombinációja és alkalmazásuk alvászavarok kezelésére és/vagy megelõzésére | |
| GB201522828D0 (en) | Prevention and treatment of glaucoma | |
| GB201706823D0 (en) | Treatment of psychological disorders |